# Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients

> **NCT03155516** · NA · UNKNOWN · sponsor: **Taiwan Mundipharma Pharmaceuticals Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Cancer
- Pain

## Interventions

- **OTHER:** Good pain management (GPM) procedure
- **OTHER:** Current practice procedure

## Key facts

- **NCT ID:** NCT03155516
- **Lead sponsor:** Taiwan Mundipharma Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-30
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03155516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03155516, "Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03155516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*